APOPTOSIS INDEX, EXPRESSION p53,  Bcl-2, AND ANGIOGENESIS  IN RECCURENCE ENDOMETRIAL HYPERPLASIA PATIENTS by Hardian, H et al.
13 
 
P13 
 
APOPTOSIS INDEX, EXPRESSION p53,  Bcl-2, AND ANGIOGENESIS  IN 
RECCURENCE ENDOMETRIAL HYPERPLASIA PATIENTS 
 
Hardian1, Neni Susilaningsih2,  Ratna Damma Purnawati2, Nurwijayahadi3,  Muhammad  Wajdi4 
1Department of Physiology, 2Department of Histology, 3Department of Pharmacology, 4Department of Anatomy 
Faculty of Medicine,  Diponegoro University, Indonesia 
 
 
Endometrial carcinoma is the most common cause of death among all gynecologic 
malignancies. It is generally accepted that endometrial hyperplasia represents precursor lesions 
for endometrial carcinoma. The aim of this study was to investigate the correlation between 
clinical findings with apoptosis, expression of p53 and Bcl-2 in recurrence endometrial 
hyperplasia patients.  
The study was conducted in Dr. Kariadi General Hospital Semarang. Research subjects 
were 22 patients with recurrence endometrial hyperplasia. Endometrial tissue samples were 
collected by hysteroscopy. Clinical findings were categorized based on the present (+) or absence 
(-) of Cork and Screw (CS) vascularisation appearance on endometrial tissue during 
hysteroscopy.  Apoptosis index  was evaluated by Tunnel assay method. Expression of p53 and 
BCL-2 were examined by immunohistochemical methods. Apoptosis, p53 and Bcl-2 expressions 
on CS (+) was significantly higher than CS (-) group (p<0,05). CS appearance was significantly 
associated with the present of in situ endometrial carcinoma (p<0.05). Hysteroscopy clinical 
findings was significantly correlated with apoptosis index (p<0.001) and p53 expression (p-
0.01), however, not correlated with Bcl-2 expression (p=0.6). Clinical findings of recurrence 
endometrial hyperplasia were associated with the apoptosis and p53 expression.   
 
Keywords: Endometrium, hyperplasia, apoptosis, p53, Bcl-2 
 
